Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Shares Outstanding (2010 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Shares Outstanding (Entity) came in at $1.3 million in Q3 2024, down 4.4% year-over-year from $1.4 million in Q4 2023, and down 0.62% quarter-over-quarter from $1.3 million in Q2 2024.

Analysis

Creative Medical Technology Holdings (CELZ) Shares Outstanding (2010 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Shares Outstanding (Entity) for 15 consecutive years, with $1.3 million the latest figure, recorded in Q3 2024.

  • On a quarterly basis, Shares Outstanding (Entity) fell 4.4% year-over-year to $1.3 million in Q3 2024; TTM through Sep 2024 was $1.3 million, a 4.4% decrease from a year earlier, with the FY2023 full-year figure at $1.4 million, up 25.65% from the prior year.
  • Shares Outstanding (Entity) was $1.3 million for Q3 2024 at Creative Medical Technology Holdings, down from $1.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $136.3 million in Q3 2020 and troughed at $227712.0 in Q1 2021.
  • A 5-year average of $10.6 million and a median of $1.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) jumped 2701.18% in 2020 and slumped 99.82% in 2021, its largest moves.
  • Over 5 years, Shares Outstanding (Entity) stood at $29.0 million in 2020, then sank by 99.1% to $260506.0 in 2021, then soared by 319.65% to $1.1 million in 2022, then climbed by 25.65% to $1.4 million in 2023, then decreased by 3.19% to $1.3 million in 2024.
  • The last three Shares Outstanding (Entity) figures came in at $1.3 million (Q3 2024), $1.3 million (Q2 2024), and $1.4 million (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 29.53 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - 96.51 Mn
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn 450.19 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 184.32 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn 66.24 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn - 104.33 Mn
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 356.89 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn 105.43 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 51.08 Mn
10 Creative Medical Technology Holdings 1.48 Mn 1.50 Mn - 1.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.39 Mn
Mar 31, 2026 1.39 Mn
Dec 31, 2025 1.39 Mn
Sep 30, 2025 1.39 Mn
Jun 30, 2025 1.39 Mn
Mar 31, 2025 1.39 Mn
Dec 31, 2024 1.39 Mn
Sep 30, 2024 1.39 Mn
Jun 30, 2024 1.41 Mn
Mar 31, 2024 1.42 Mn
Dec 31, 2023 1.41 Mn
Sep 30, 2023 1.43 Mn
Jun 30, 2023 1.41 Mn
Mar 31, 2023 1.41 Mn
Dec 31, 2022 1.09 Mn
Sep 30, 2022 1.41 Mn
Jun 30, 2022 901,125.00
Mar 31, 2022 645,402.00
Dec 31, 2021 260,506.00
Sep 30, 2021 245,208.00